Skip to content
Blog News
About Us
Contact Us
Blog News
About Us
Contact Us
Log In
Home
Blog News
About Us
Contact Us
Login
Clostridium difficile
Clostridium difficile
Latest Posts
Cidrap EDU
,
Clostridium difficile
,
RSS
Trial data show Rebyota is safe, effective in immune-compromised patients with recurrent C diff
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
Study examines C diff recurrence, risk factors in cancer patients
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
Study highlights demographic, socioeconomic disparities in C difficile infection
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
Fidaxomicin underused for C diff infections, study finds
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
VA trial finds no reduction in C diff recurrence after fecal microbiota therapy
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
Narrow-spectrum drug shows promise against C diff infection in phase 2 trial
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
C difficile vaccine candidate fails to meet primary end point in phase 3 trial
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
Study reveals how microbiota-based treatment may help prevent recurrent C diff
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
Specialist-led intervention program linked to better management of C diff patients
April 4, 2025
Cidrap EDU
,
Clostridium difficile
,
RSS
Rebyota fecal transplant offers durable protection after antibiotic exposure, study finds
April 4, 2025
Page
1
Page
2
Applicants List
Loading...
Close
Candidate's Applied Jobs
Loading...
Close
Company Jobs
Loading...
Close
Edit Company
Loading...
Close
Edit Candidate
Loading...
Close
Edit Job
Loading...
Close
